# Northpond Ventures: portfolio, investments and team

> Northpond Ventures is a private equity based in United States. 45 investments on record, 5 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/northpond-ventures (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Northpond Ventures

Last cheque observed Oct 2026; 45 cheques on record.

Deploying now New fund, Aug 2024 Private equity

Seed Series A Series B AI & Machine Learning Advanced Materials AgTech (FarmTech)

Deploying now

**50%** of best year **5** **cheques in 12 months**, 45 on record

Since the last cheque **11** days **00** hrs **00** min **00** sec

Median round **$23M** Cheque size, as they say **$1.0M – $5.0M** Rounds led **8 of 45** Sole investor **6 rounds** Mostly in **United States, 89%**

Pitch Northpond Ventures

## Northpond Ventures highlights

- 01 5 cheques in the last 12 months
- 02 Mostly Series A and Series B: 63% of its rounds
- 03 Sole investor in 6 rounds, median $27M

## What they do

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** $1.0M – $5.0M as they say
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** AI & Machine Learning Advanced Materials AgTech (FarmTech)
- **Based in:** Bethesda, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **45 appearances**

- **2026** 4 rounds
- **Oct** **[OMass Therapeutics](https://millionrounds.com/company/omass-therapeutics)** Series C · GB · Jefferson Life Sciences **$310M** With 12 others
- **Sept** **[Transition Bio](https://millionrounds.com/company/transition-bio)** Grant · US **$750K** Sole investor
- **Jan** **[VieCure](https://millionrounds.com/company/viecure)** Growth · US · Socium Ventures **$43M** *Led*
- **Jan** **[Vizgen](https://millionrounds.com/company/vizgen)** Series E · US **$48M** With 1 other
- **2025** 5 rounds
- **Nov** **[Elephas](https://millionrounds.com/company/elephas)** Venture · US **$40M** With 2 others
- **May** **[QbDVision](https://millionrounds.com/company/qbdvision)** Series A · US **$13M** With 2 others
- **May** **[Outcomes4Me](https://millionrounds.com/company/outcomes4me)** Series A · US **$21M** With 2 others
- **Feb** **[EnPlusOne Biosciences](https://millionrounds.com/company/enplusone-biosciences)** Venture · US **$10M** With 1 other
- **Feb** **[OPT Industries](https://millionrounds.com/company/opt-industries)** Venture · US **Undisclosed** With 3 others
- **2024** 6 rounds
- **Oct** **[Transition Bio](https://millionrounds.com/company/transition-bio)** Venture · US **$13M** Sole investor
- **Sept** **[Inflammatix](https://millionrounds.com/company/inflammatix)** Series E · US **$57M** With 2 others
- **Aug** **[Kytopen](https://millionrounds.com/company/kytopen)** Grant · US **$1.6M** With 2 others
- **Jul** **[Ultivue](https://millionrounds.com/company/ultivue)** Venture · US **$3.3M** With 2 others
- **Apr** **[SeLux Diagnostics](https://millionrounds.com/company/selux-diagnostics)** Series D · US **$48M** With 3 others
- **Apr** **[Slingshot Biosciences](https://millionrounds.com/company/slingshot-biosciences)** Series A · US **$15M** With 1 other
- **2023** 7 rounds
- **Dec** **[Totus Medicines](https://millionrounds.com/company/totus-medicines)** Series B · US **$66M** With 1 other
- **Nov** **[Aro Biotherapeutics](https://millionrounds.com/company/aro-biotherapeutics)** Series B · US **$42M** Sole investor
- **Nov** **[Scitara](https://millionrounds.com/company/scitara)** Series B · US **$15M** With 1 other
- **Nov** **[Scitara](https://millionrounds.com/company/scitara)** Series B · US **$8.5M** With 1 other
- **May** **[Telesis Bio](https://millionrounds.com/company/telesis-bio)** US **$74M** Sole investor
- **May** **[OMass Therapeutics](https://millionrounds.com/company/omass-therapeutics)** Series B · GB **$13M** With 3 others
- **Feb** **[Faro AI](https://millionrounds.com/company/faro-ai)** Series A · US **$20M** With 4 others
- **2022** 8 rounds
- **Nov** **[Opna Bio](https://millionrounds.com/company/opna-bio)** Series A · CH **$38M** With 2 others
- **Sept** **[Isolere Bio](https://millionrounds.com/company/isolere-bio)** Grant · US **$75K** With 3 others
- **Jun** **[Code Biotherapeutics](https://millionrounds.com/company/code-biotherapeutics)** Series A · US **$75M** With 2 others
- **Mar** **[Triumvira Immunologics](https://millionrounds.com/company/triumvira-immunologics)** Series A · US **$45M** With 1 other
- **Mar** **[Nanoview Biosciences](https://millionrounds.com/company/nanoview-biosciences)** Debt · US **$2.5M** With 3 others
- **Feb** **[Walking Fish Therapeutics](https://millionrounds.com/company/walking-fish-therapeutics)** Series A · US **$23M** With 1 other
- **Feb** **[Story Health](https://millionrounds.com/company/story-health)** Series A · US **$23M** With 3 others
- **Feb** **[1859](https://millionrounds.com/company/1859)** Series A · US **$40M** With 1 other
- **2021** 4 rounds
- **Oct** **[SimBioSys](https://millionrounds.com/company/simbiosys)** Series A · US **$15M** With 1 other
- **Sept** **[Kytopen](https://millionrounds.com/company/kytopen)** Series A · US · Firms' own news pages **$30M** *Led*
- **Aug** **[Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience)** Series B · US · Hatteras Venture Partners **$90M** With 12 others
- **Jun** **[Hawthorne Effect](https://millionrounds.com/company/hawthorne-effect)** Series A **$20M** With 2 others
- **2020** 2 rounds
- **Nov** **[ArtisanBio](https://millionrounds.com/company/artisanbio)** Series A **$21M** With 1 other
- **Nov** **[Refeyn](https://millionrounds.com/company/refeyn)** Series A **$30M** With 2 others
- **2019** 8 rounds
- **Dec** **[ChromaCode](https://millionrounds.com/company/chromacode)** Series C · US · FinSMEs **$28M** *Led*
- **Sept** **[SGI-DNA](https://millionrounds.com/company/sgi-dna)** Series A · US · FinSMEs **$25M** *Led*
- **Aug** **[SpeeDx](https://millionrounds.com/company/speedx)** AU · FinSMEs **$100M** Sole investor
- **May** **[IsoPlexis](https://millionrounds.com/company/isoplexis)** Series C · US · FinSMEs **$25M** *Led*

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **1 named**

MP **Michael Pinchas Rubin** Managing Member i Filing they signed

We also hold **18** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$1.7B** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Northpond Ventures, LLC
- **SEC number:** CRD 297265

New fund on file

**Raised**

a new fund in Aug 2024

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$23M** the round, not its cheque Alone, median **$27M**

Led 8 of 45 rounds **18%**

- **Said size:** $1.0M – $5.0M
- **Sole investor:** 6 rounds
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series A said *19*
- Series B said *6*
- Venture *5*
- Series C *4*
- Grant *3*
- Series E *3*
- Seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 4
- [National Science Foundation](https://millionrounds.com/fund/nsf-small-business-innovation-research-small-business-techno) 3
- [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) 3
- [Sands Capital Ventures](https://millionrounds.com/fund/sands-capital-ventures) 3
- [B Capital](https://millionrounds.com/fund/b-capital) 2
- [Flybridge](https://millionrounds.com/fund/flybridge) 2

**Pitching Northpond Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Northpond Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**ARCH Venture Partners** VC firm **4** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**National Science Foundation** Government **3** rounds together](https://millionrounds.com/fund/nsf-small-business-innovation-research-small-business-techno)[**Oxford Science Enterprises** VC firm **3** rounds together](https://millionrounds.com/fund/oxford-science-enterprises)[**Sands Capital Ventures** Private equity **3** rounds together](https://millionrounds.com/fund/sands-capital-ventures)[**B Capital** VC firm **2** rounds together](https://millionrounds.com/fund/b-capital)[**Flybridge** VC firm **2** rounds together](https://millionrounds.com/fund/flybridge)[**General Catalyst** VC firm **2** rounds together](https://millionrounds.com/fund/general-catalyst)[**Google Ventures** Corporate VC **2** rounds together](https://millionrounds.com/fund/gv)[**Hatteras Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/hatteras-venture-partners)[**Horizons Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/horizons-ventures)[**National Institutes of Health** Government **2** rounds together](https://millionrounds.com/fund/national-institutes-of-health)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)

## Recently backed

The latest companies Northpond Ventures put money into.

[**OMass Therapeutics** $310M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**Transition Bio** $750K · Sept 2026](https://millionrounds.com/company/transition-bio)[**VieCure** $43M · Jan 2026](https://millionrounds.com/company/viecure)[**Vizgen** $48M · Jan 2026](https://millionrounds.com/company/vizgen)[**Elephas** $40M · Nov 2025](https://millionrounds.com/company/elephas)[**QbDVision** $13M · May 2025](https://millionrounds.com/company/qbdvision)

## Quick answers about Northpond Ventures

### What does Northpond Ventures invest in?

Northpond Ventures invests most often at Series A and Series B (63% of the rounds on record), in sectors such as AI & Machine Learning, Advanced Materials and AgTech (FarmTech).

### How active is Northpond Ventures?

45 investments on record, 5 of them in the last 12 months, and it led 8. The most recent was in Oct 2026.

### What has Northpond Ventures invested in recently?

Its most recent investments on record: OMass Therapeutics (Series C, Oct 2026), Transition Bio (Grant, Sept 2026) and VieCure (Growth, Jan 2026).

### How big are Northpond Ventures's cheques?

The median round it joins is $23M. It says it writes cheques of $1.0M to $5.0M.

### Does Northpond Ventures lead rounds?

Yes: it led 8 of its 45 investments on record (18%).

### Where does Northpond Ventures invest?

Most of the companies it backs are in the United States (89%) and the United Kingdom (5%).

### Is Northpond Ventures investing now?

Yes: it is actively investing, with 5 investments in the last 12 months.

### Who does Northpond Ventures invest alongside?

Most often ARCH Venture Partners (4 rounds together), National Science Foundation (3 rounds together) and Oxford Science Enterprises (3 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=northpond-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=northpond-ventures)